NO20081541L - New sea lice vaccine - Google Patents

New sea lice vaccine

Info

Publication number
NO20081541L
NO20081541L NO20081541A NO20081541A NO20081541L NO 20081541 L NO20081541 L NO 20081541L NO 20081541 A NO20081541 A NO 20081541A NO 20081541 A NO20081541 A NO 20081541A NO 20081541 L NO20081541 L NO 20081541L
Authority
NO
Norway
Prior art keywords
protein
nucleic acid
acid sequences
sea lice
vaccines
Prior art date
Application number
NO20081541A
Other languages
Norwegian (no)
Inventor
Petter Frost
Frank Nilsen
Lars Are Hamre
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of NO20081541L publication Critical patent/NO20081541L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Foreliggende oppfinnelse angår et 200 kD protein, et 180 kD protein, et 100/85 kD protein og et 79 kD protein. Oppfinnelsen angår videre nukleinsyresekvenser som koder for et 200 kD protein, et 180 kD protein, et 100/85 kD protein og et 79 kD protein, vaksiner omfattende disse proteiner eller nukleinsyresekvenser som koder for proteinene, DNA-fragmenter, rekombinante DNA-molekyler, levende rekombinante bærere og vertsceller omfattende slike nukleinsyresekvenser, vaksiner omfattende slike DNA-fragmenter, rekombinante DNA-molekyler, levende rekombinante bærere og vertsceller omfattende slike nukleinsyresekvenser, metoder for fremstilling av slike vaksiner og anvendelse av slike protein- eller nukleinsyresekvenser som koder for slike proteiner i vaksiner og fremstilling av en vaksine for bekjemping av sjølus-infeksjon i salmonider.The present invention relates to a 200 kD protein, a 180 kD protein, a 100/85 kD protein and a 79 kD protein. The invention further relates to nucleic acid sequences encoding a 200 kD protein, a 180 kD protein, a 100/85 kD protein and a 79 kD protein, vaccines comprising these proteins or nucleic acid sequences encoding the proteins, DNA fragments, recombinant DNA molecules, living recombinant carriers and host cells comprising such nucleic acid sequences, vaccines comprising such DNA fragments, recombinant DNA molecules, living recombinant carriers and host cells comprising such nucleic acid sequences, methods of producing such vaccines and use of such protein or nucleic acid sequences as such and preparation of a vaccine for combating sea lice infection in salmonids.

NO20081541A 2005-10-05 2008-03-31 New sea lice vaccine NO20081541L (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05109261 2005-10-05
EP05109260 2005-10-05
EP05109258 2005-10-05
EP05109259 2005-10-05
PCT/EP2006/066978 WO2007039599A1 (en) 2005-10-05 2006-10-03 Novel sea lice vaccine

Publications (1)

Publication Number Publication Date
NO20081541L true NO20081541L (en) 2008-07-02

Family

ID=37696028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081541A NO20081541L (en) 2005-10-05 2008-03-31 New sea lice vaccine

Country Status (7)

Country Link
EP (1) EP1934247A1 (en)
JP (1) JP2009511005A (en)
CA (1) CA2624486A1 (en)
DK (2) DK200800635A (en)
NO (1) NO20081541L (en)
TW (1) TW200801034A (en)
WO (1) WO2007039599A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789554B1 (en) * 2004-07-28 2018-07-04 National Research Council Of Canada Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
CU23634A1 (en) * 2007-05-31 2011-02-24 Ct Ingenieria Genetica Biotech SEQUENCES OF NUCLEIC ACID AND AMINO ACIDS, AND VACCINE FOR THE CONTROL OF INFESTATIONS BY ECTOPARASITES IN FISH
EP2211900A1 (en) 2007-11-19 2010-08-04 Calanus AS Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
GB201902425D0 (en) * 2019-02-22 2019-04-10 Benchmark Animal Health Ltd Sea lice antigens and vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789554B1 (en) * 2004-07-28 2018-07-04 National Research Council Of Canada Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof

Also Published As

Publication number Publication date
EP1934247A1 (en) 2008-06-25
DK201070087A (en) 2010-03-05
CA2624486A1 (en) 2007-04-12
TW200801034A (en) 2008-01-01
WO2007039599A1 (en) 2007-04-12
JP2009511005A (en) 2009-03-19
DK200800635A (en) 2008-05-05

Similar Documents

Publication Publication Date Title
EA201071323A1 (en) AXMI-115, AXMI-113, AXMI-005, AXMI-163, AXMI-184 INSECTICIDE PROTEINS AND METHODS OF THEIR APPLICATION
ATE470673T1 (en) VACCINES CONTAINING LAWSONIAINTRACELLULAR SUBUNIT
HUP0105379A2 (en) Lawsonia intracellularis vaccine
EA201170635A1 (en) COMPOSITIONS, METHODS OF OBTAINING AND APPLICATION OF THE FRAMEWORK ON THE BASIS OF FIBRONECTIN TYPE III DOMAIN
WO2006119987A3 (en) Recombinant n-glycosylated proteins from procaryotic cells
NZ591415A (en) Haemophilus influenzae type B
WO2006120230A3 (en) Host cell specific binding molecules capable of neutralizing viruses and uses thereof
BR112014001978A2 (en) axmi205 variant proteins and methods for using them
BRPI0411363A (en) nucleic acid sequences encoding and compositions comprising signal peptide ige and / or il-15 and processes for use thereof
ATE473236T1 (en) ANTIGENS OF PISCIRICKETTSIA SALMONIS AND THEIR USE
NO20081541L (en) New sea lice vaccine
ATE450545T1 (en) LAWSONIA INTRACELLULARIS SUBUNIT VACCINE
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
NO20051561L (en) Nucleic acid molecules encoding human papillomavirus and their use in vaccine.
ZA200602107B (en) Piroplasmid vaccine
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
WO2007127290A3 (en) Method for producing viral vaccine and therapeutic peptide antigens
ATE450546T1 (en) VACCINES CONTAINING ORNITHOBACTERIUM RHINOTRACHEALE SUBUNIT
HUP0200832A2 (en) Babesia canis vaccine
WO2004024769A3 (en) Ostertagia vaccine
WO2005123121A3 (en) Use of dna molecule as vaccine adjuvant
AR040830A1 (en) VACCINE TO COMBAT THE INFECTION THAT PRODUCES THE MASTITIS
TH88495A (en) A new vaccine for marine parasites
DK1176192T3 (en) Helicobacter felis vaccine
TH88495B (en) A new vaccine for marine parasites

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application